Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants ...Middle East

SINGAPORE, Dec. 9, 2025 /PRNewswire/ -- Immortal Dragons, the $40 million longevity-focused innovation fund, today announced its strategic investment in Etheros, a research-driven technology company developing proprietary water-soluble fullerene-based catalytic antioxidant materials....

Hence then, the article about immortal dragons backs etheros pharmaceuticals targeting aging related disease with breakthrough catalytic antioxidants was published today ( Wednesday 10/12/2025 - 01:15 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Immortal Dragons Backs Etheros Pharmaceuticals: Targeting Aging-Related Disease with Breakthrough Catalytic Antioxidants )

Also on site :

• Maduro Could Have Avoided His Capture Entirely if He Had Checked This App
• Sydney Sweeney covers W magazine in nothing but gold body paint
• ‘He broke’: 93-year-old Fremont man told police he spent month planning to kill wife, docs say